Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer (CRITICAL)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2011 by Bostwick Laboratories.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Prostate Institute of America
Community Memorial Hospital
HemaCare Corporation
Information provided by (Responsible Party):
Bostwick Laboratories
ClinicalTrials.gov Identifier:
NCT00753220
First received: September 12, 2008
Last updated: September 20, 2011
Last verified: September 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2011
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)